Remove Branding Remove Genetics Remove Hormones
article thumbnail

A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica

Delveinsight

Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist. If approved, it will be marketed under the brand name Orgovyx for prostate cancer as well as in women’s health in combination with estradiol 1.0 mg and norethindrone acetate (0.5 mg) in the US and Canada.

Trials 52
article thumbnail

Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data

XTalks

Sandostatin (Octreotide) Sandostatin 2022 sales: $1.238 billion Company/Developer: Novartis Date of first FDA approval: October 21, 1988 Indications Sandostatin is FDA-approved for: Sandostatin is a synthetic protein closely resembling the natural hormone somatostatin in the human body. Price of Zoladex: The cost of Zoladex (subcutaneous 3.6

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

First Participant Dosed in Pfizer’s Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib and Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

The Pharma Data

The prognosis for men with advanced prostate cancer has significantly improved since the introduction of novel hormone therapies, but additional therapeutic options are needed for the approximately 25 percent of men with tumors harboring DNA damage response (DDR) gene mutations, who may have poorer outcomes,” said Chris Boshoff, M.D.,

DNA 52
article thumbnail

Top 40 Best-Selling Cancer Drugs in 2023 by 2022 Data

XTalks

Sandostatin (Octreotide) Sandostatin 2022 sales: $1.238 billion Company/Developer: Novartis Date of first FDA approval: October 21, 1988 Indications Sandostatin is FDA-approved for: Sandostatin is a synthetic protein closely resembling the natural hormone somatostatin in the human body. Price of Zoladex: The cost of Zoladex (subcutaneous 3.6

article thumbnail

Diamyd Medical with MainlyAI and KTH awarded VINNOVA funding for AI driven sustainable production

The Pharma Data

Within the scope of the ALISTAIR project, there is a unique opportunity to design, implement, and evaluate the project results to the brand-new drug production facility being setup by Diamyd Medical in Umeå, the Capital of Västerbotten County in Sweden. About Diamyd Medical Diamyd Medical develops therapies for type 1 diabetes.

article thumbnail

The Flat Belly Transformation

The Pharma Data

In a moment, I’m going to share with you a BRAND-NEW fat-loss method called Flat Belly Transformation. Your body’s hormones are destroyed from almost a year of starvation. For the first time in 5 years, I’m releasing a BRAND-NEW and updated version of my original best-selling book…. … Which makes sense given I have 17.5”

article thumbnail

Rare but Prevalent: The Unequal Toll of Rare Diseases on Women

Intouch Solutions

The exact reasons why rare diseases are more present in women than men are unknown, but some of the hypotheses include hormonal factors, genetic predisposition and womens stronger immune systems. Learn more about how your brand can drive outcomes and impact in rare disease.